An2 Therapeutics (ANTX)'s 30-day implied volatility (IV30) was 67.2% at the close on October 26, 2026, down from 82.9% the day before, against a 52-week range of 60.7% to 106.7%. Its 20-day historical volatility was 92.4%.
Data as of October 26, 2026.